AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2024
May 29, 2024
35274_dirs_2024-05-29_e250652f-9a70-4e59-a1db-4709866b1876.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2024-05-28
Reporting Person: Williams Donald Allen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-28 | Comon Stock, par value $0.01 | P | 1000 | $4.863 | Acquired | 1000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Comon Stock, par value $0.01 | 2000 | Indirect |
Footnotes
F1: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.863 on May 28, 2024.
More from PALISADE BIO, INC.
Capital/Financing Update
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Capital/Financing Update
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11